Diasia Biomedical Technology Co., Ltd.
Shenzhen DIASIA Biomedical Technology Co., Ltd. was founded in 2013. The company has been deeply involved in research and develop the IVD instruments and reagents for many years, in the areas for PCR technology, hematology analysis, clinical chemistry, immunofluorescence, pathological staining, rapid tests, Diasia has been constructing its medical products system, and created billions of business value, particularly developed the variety POC machines and built the self-developed intelligent medical data management system. Diasia has more than 120 patents, will continue to develop the technique and skills, at the same time provides better service for global partners. Diasia, as a Chinese enterprise who has a sense of mission, has been committing itslef to raise the ceiling on human health unremittingly, and will continue to work for it.
Patents & Certificates
As the leading company in China on Auto Pathology Analyzer and iPOCT Analyzer, Diasia Biomedical devotes into innovation and leading-edge technologies, holding 100+ patents and copy rights as well as 100+ registrations globally on biomedical products.
The first phase of the IF Salon of the National Innovation Center, the special activities of Russian medical device registration and going to sea were successfully held